1-15 of 15
Keywords: Antiplatelet agents
Sort by
Journal Articles
Journal Articles
Cerebrovasc Dis (2001) 11 (Suppl. 1): 49–54.
Published Online: 01 April 2010
...David G. Sherman Both anticoagulants and antiplatelet agents have been advocated, used and studied for the treatment of acute ischemic stroke. Randomized trials of unfractionated heparin, low-molecular-weight heparin and heparinoids have failed to show an overall benefit to these agents largely...
Journal Articles
Cerebrovasc Dis (2009) 28 (6): 611–617.
Published Online: 22 October 2009
... disorders in young adults with acute cerebral ischaemia. J Neurol 1998;245:21–25. Coagulopathy Cryptogenic cerebral ischemia Antiplatelet agents Anticoagulation Stroke etiology remains undetermined in a substantial proportion of patients with an ischemic stroke or transient ischemic attack...
Journal Articles
Cerebrovasc Dis (2007) 24 (2-3): 215–218.
Published Online: 28 June 2007
... with anticoagulant therapy were excluded from the study. Results: Of 457 consecutive patients with cerebral hemorrhage, 94 (20.5%) had been taking antiplatelet agents. The treated patients (mean age for antiplatelet group 78.9 ± 9.0 years) were older than the nontreated patients (73.8 ± 9.4, p = 0.02). In-hospital...
Journal Articles
Cerebrovasc Dis (2006) 22 (5-6): 342–349.
Published Online: 02 November 2006
... to in the content or advertisements. Antiplatelet agents Brain infarction Carotid surgery Intracerebral haemorrhage Neuroprotective agents Statins Stroke prevention Stroke units Subarachnoid haemorrhage Thrombolysis As a first-year medical student I heard of a young talented neurosurgeon...
Journal Articles
Cerebrovasc Dis (2000) 10 (Suppl. 5): 41–48.
Published Online: 17 November 2004
... to blocking a single metabolic pathway – namely inhibition of thromboxane A 2 formation –, and aspirin fails to alter platelet adhesion, other antiplatelet agents that target ADP receptors, platelet surface glycoproteins (such as the GPIIb/IIIa complex), or platelet-dependent thrombin generation offer...
Journal Articles
Cerebrovasc Dis (2003) 17 (Suppl. 1): 74–80.
Published Online: 29 December 2003
... mortality, the estimated odds ratio for clopidogrel versus placebo was 0.70 (95% CI 0.64–0.78, p < 0.000001), a relative risk reduction of 30% [ 24 ]. Stroke Prevention Antiplatelet agents Acetylsalicylic acid Dipyridamole Clopidogrel Atherosclerosis is the most prevalent disease...
Journal Articles
Cerebrovasc Dis (2002) 13 (Suppl. 1): 12–16.
Published Online: 18 January 2002
... events, including antiplatelet agents, anticoagulants, angiotensin-converting enzyme inhibitors and statins. Several antiplatelet agents are approved to reduce the risk of recurrent stroke, although only clopidogrel and acetylsalicylic acid (ASA) are approved for the reduction of both stroke and MI...
Journal Articles
Cerebrovasc Dis (2001) 11 (4): 324–329.
Published Online: 24 May 2001
.... Kaps M, Hansen J, Weiher M, Tiffert K, Kayser I, Droste DW: Clinically silent microemboli in patients with artificial prosthetic aortic valves are predominantly gaseous and not solid. Stroke 1997;28:322–325. Antiplatelet agents Acetylsalicylic acid Carotid artery stenosis Cerebral embolism...
Journal Articles
Cerebrovasc Dis (2001) 11 (Suppl. 2): 11–17.
Published Online: 12 April 2001
... clopidogrel is associated with a one-third increase in the odds of rash and of diarrhoea. Only ticlopidine increases the odds of neutropenia compared with aspirin. There is no clear evidence as yet for the benefit of dipyridamole or an oral GP IIb/IIIa receptor antagonist as single antiplatelet agents...
Journal Articles
Cerebrovasc Dis (1999) 9 (4): 215–217.
Published Online: 21 June 1999
..., instructions or products referred to in the content or advertisements. Aspirin Antiplatelet agents Warfarin Anticoagulation Intracerebral hemorrhage Intracranial hemorrhage Metanalysis The risk of intracranial hemorrhage (ICH) is increased by warfarin in proportion to the intensity...
Journal Articles
Cerebrovasc Dis (1997) 7 (Suppl. 1): 22–28.
Published Online: 17 January 1997
...M. Busch; F. Masuhr; K.M. Einhäupl 17 1 1997 Stroke prevention Clinical trials Antiplatelet agents Aspirin Ticlopidine Warfarin Atrial fibrillation Anticoagulation Carotid stenosis Carotid endarterectomy 1997 Copyright / Drug Dosage / Disclaimer Copyright: All rights...
Journal Articles
Cerebrovasc Dis (1995) 5 (3): 159–162.
Published Online: 28 April 1995
... from any ideas, methods, instructions or products referred to in the content or advertisements. Clinical epidemiology Clinical trials External validity Subgroup analysis Transient ischaemic attacks Antiplatelet agents Aspirin Concerns in Stroke Ccrebrovasc Dis 1995;5:159-162 J. van Gijn...
Journal Articles
Cerebrovasc Dis (1994) 4 (Suppl. 4): 24–28.
Published Online: 23 December 1994
...John W. Harbison Antiplatelet agents have been studied extensively in clinical stroke prevention trials for 25 years. Only two have proven effective, aspirin and ticlopidine. Current data suggest that antiplatelets have a limited role in the primary prevention of stroke, and that ticlopidine...
Journal Articles
Cerebrovasc Dis (1994) 4 (Suppl. 1): 26–31.
Published Online: 30 March 1994
... of ticlopidine a reasonable one. The issue of the ''wearing off’ of the beneficial effect of antiplatelet agents is a pertinent one. A cursory review of published data suggests that the beneficial effect of antiplatelet therapy diminishes over time. The Antiplatelet Trialists'' overview analysis shows...